Related Links
Related Stories
-
Filtration Industry Mergers & Acquisitions Review 2008
Despite the tight credit markets and challenging global economy, 2008 saw further consolidation within the filtration and separation sector. Listed below are the mergers and acquisitions that took place during 2008.
Sponsored Content
-
SWRO pre-treatment: Integrity and disinfection
In the second of a series of articles, Graeme Pearce looks at the issues involved in the selection of pre-treatment technology in seawater reverse osmosis applications.
Members' Content
-
Filter testing: Parallel integrity testing of small venting filters
Filter integrity testing is critically important in biopharmaceutical production processes. However, when large numbers of filters need to be tested daily, it can be a time-consuming and costly business. Dr. Jens Meyer of Sartorius Stedim Biotech describes how this situation can be improved by parallel testing.
Members' Content
-
American Water goes Dutch on desalination technology project
American Water Works Co Inc is partnering with Netherlands-based organisations Vitens, RWB Waterservices, University of Twente, and WE Consult to launch a project on innovation in desalination technology.
-
Sartorius membrane filters can collect H1N1 virus
Sartorius water soluble gelatin membrane filters are suitable for collecting airborne viruses that cause respiratory illnesses, such as influenza viruses, which include the swine flu virus A (H1N1).
News
Key appointment for Sartorius
12 June 2009
Sartorius Stedim Biotech North America Inc. has appointed Dr. Yujing Yang as director of Purification Technologies, North America.
Sartorius Stedim Biotech says he brings broad experience in all areas of biopharmaceutical downstream processing and in-depth knowledge of biotech-related technologies, such as Xflow filtration and membrane chromatography, to Sartorius Stedim Biotech. In his current position, Dr. Yang reports to Dr. Uwe Gottschalk, vice-president of Marketing, Purification Technologies. Dr. Yang obtained both his Bachelor’s and Master’s degrees in Engineering from Tsinghua University in Beijing, China, and earned his Ph.D. in Environmental Biology at the University of Massachusetts in Boston, where he conducted research on cloning and won a number of awards. Before joining Sartorius Stedim Biotech, Dr. Yujing Yang was Industrial Commercial Leader for Life Sciences in Greater China at GE Healthcare, where he was responsible for marketing, sales and support teams. Prior to assuming this position, he was Technical Marketing director for Asia, and held various positions in business development, product management, application and technical support. Dr. Yang, who has been working in the field of biopurification for twelve years, was employed in various management and research positions at Pall Corporation, the U.S. National Research Council and the Boston Biomedical Research Institute. He also taught as an Assistant Professor for three years at Tsinghua University and has four bioprocessing patents to his name.
This article is featured in:
Pharma and biotech
Comment on this article
You must be registered and logged in to leave a comment
about this article.